Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 known ✓ | P04629 | 1/20 | 0.31 |
| ▸ | MAP2K2 known ✓ | P36507 | 1/20 | 0.31 |
| ▸ | MAP2K1 known ✓ | Q02750 | 1/20 | 0.31 |
| ▸ | NTRK3 known ✓ | Q16288 | 1/20 | 0.31 |
| ▸ | NTRK2 known ✓ | Q16620 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4798019 | 0.97 | CYP1A2 (0.35) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Sulfuric Acid SCHEMBL3253536 | 0.86 | CYP1A2 (0.33) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Sulfuric Acid SCHEMBL31206216 | 0.86 | CYP1A2 (0.33) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Hydrochloric Acid SCHEMBL28174894 | 0.80 | PI4KA (0.42) | KDM4EGAALRRK2RETCHEK1 | |
| Sulfuric Acid SCHEMBL10962909 | 0.75 | PRMT1 (0.35) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Sulfuric Acid SCHEMBL28904638 | 0.73 | MEN1 (0.39) | CYP3A4KDM4EGAAMEN1MAPT | |
| Sulfuric Acid SCHEMBL6474843 | 0.72 | CDK1 (0.42) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Sulfuric Acid SCHEMBL31415093 | 0.72 | CDK1 (0.42) | CYP1A2CYP3A4NFKB1THPOBLM | |
| Sulfuric Acid SCHEMBL8028117 | 0.72 | MEN1 (0.38) | CYP1A2CYP3A4TDP1KDM4EGAA | |
| Adenine SCHEMBL27690901 | 0.71 | PI4KA (0.40) | CYP1A2CYP3A4NFKB1THPOBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170328837-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-11-16 | — | — | US | claimed |
| US-9689801-B2 | SERS-based analyte detection | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-27 | — | — | US | claimed |
| EP-2516995-B1 | SERS-BASED ANALYTE DETECTION | AGENCY SCIENCE TECH & RES (SG) | 2016-10-26 | — | — | EP | claimed |
| CN-102812348-B | Analysis quality testing based on SERS is surveyed | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-02-03 | — | — | CN | claimed |
| US-20130023435-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-01-24 | — | — | US | claimed |
| EP-2516995-A1 | SERS-BASED ANALYTE DETECTION | Agency For Science, Technology And Research (SG) | 2012-10-31 | — | — | EP | claimed |
| WO-2011078794-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-30 | — | — | WO | claimed |
| US-20250327028-A1 | ENGINEERED PLATELETS AS TARGETED PROTEIN DEGRADERS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-10-23 | — | — | US | disclosed |
| US-12054768-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-06 | — | — | US | disclosed |
| US-20240094187-A1 | SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES | BECKMAN COULTER, INC. (US) | 2024-03-21 | — | — | US | disclosed |
| CN-117120828-A | Surface enhanced Raman spectroscopy for detection of analytes | 贝克曼库尔特有限公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-4271984-A1 | SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES | Beckman Coulter, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-4123031-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | The Regents of The University of California (US) | 2023-01-25 | — | — | EP | disclosed |
| WO-1993006522-A1 | PROCESS FOR THE PREPARATION OF HIGH CHLORIDE TABULAR GRAIN EMULSIONS (IV) | EASTMAN KODAK COMPANY (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0534323-A1 | Process for the preparation of high chloride tabular grain emulsions (II) | EASTMAN KODAK COMPANY (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5185239-A | Triaminopyridine grain growth modifier | EASTMAN KODAK COMPANY (US) | 1993-02-09 | — | — | US | disclosed |
| US-5178997-A | A fused N-heterocyclic compound as a grain growth modifier; materials handling | EASTMAN KODAK COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5047405-A | Alzheimer*s disease | BIORESEARCH S.P.A. (IT) | 1991-09-10 | — | — | US | disclosed |
| EP-0290819-A2 | Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity | BIORESEARCH S.p.A. (IT) | 1988-11-17 | — | — | EP | disclosed |
| US-4187307-A | 4-AMINOPTERIDINES | ABBOTT LABORATORIES (US) | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250327028-A1 | ENGINEERED PLATELETS AS TARGETED PROTEIN DEGRADERS | HSP90B1, HSP90AB1, HSP90AA1 | NTRK1 2983/4885MAP2K2 2888/4885MAP2K1 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.